YDES

YD Bio Ltd

Nasdaq· Services-Medical Laboratories· Inc. E9· CIK 0002011674 Healthcare & Medical Devices

$5.29 +0.34 (+6.87%)

Oct 26 4:00 PM ET · prev $4.95

Market cap

$300.3M

Small cap

1 year

−69.1%

from $17.11 · Oct 27

30 days

−25.6%

from $7.11

52-week range

$1.90–17.11

−69% from high · low Jul 2

Avg volume 20D

186.3K

Oct 2 spike 546.6K

Short interest

🔒 Subscribers only

Insider net

+$128.5K

1 buyer · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 2 reports · 90 days

Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score

Avg score

Strongest BEARISH YD Bio reported financial results for the six months ended June 30, 2026, showing headline net income of…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Apr 30 YD Bio reported FY2025 net revenue of $597K (+17% YoY) but net loss…
X Jul 31 Short interest falls 35.1% to 16.3K
R Aug 31 YD Bio reported financial results for the six months ended June 30,…
E Aug 31 Trading halt: Halt Resumed: YDES — trading resumed after LUDP (Volatilit…
E Aug 31 Trading halt: Trading Halt: YDES — LUDP (Volatility Trading Pause)
B Sep 4 to Sep 14 3 days of insider buys: $128.5K by 1 insider, avg $3.76
X Sep 15 Short interest jumps 223.2% to 43.0K
X Sep 30 Short interest jumps 312.8% to 177.3K

Signal stack

Where each data set points today.

InsidersBULLISH

1 insider bought $128.5K at an average $3.76. No open-market sales. Price is 41% above their cost.
InstitutionsMIXED

Q2 2026: 1 added (0 new), 1 trimmed or exited.
TrendUPTREND

6% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
CITADEL ADVISORS LLC	ADD	30,106	$67.7K
MORGAN STANLEY	TRIM	160	$360.00

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Sep 30, 2026 Insider

Chang Kochi acquired via exercise 3,135 shares

Director

Sep 30, 2026 Insider

Lu Shao-Ta acquired via exercise 3,135 shares

Director

Sep 30, 2026 Insider

Chang Kochi was granted 3,135 shares

Director

Sep 23, 2026 Earnings calendar

YDES Q2 2026 Earnings Scheduled — 2026-09-23

Aug 31, 2026 SEC

YD Bio reported financial results for the six months ended June 30, 2026, showing headline net income of $6.7M (vs a…

PRESS-RELEASE — Impact 6/10

Aug 11, 2026 SEC

YD Bio announced the launch of two nutraceutical products in Taiwan under a new physician-partnership model…

6-K — Impact 3/10

Jun 30, 2026 Inst.

CITADEL ADVISORS LLC — ADD

30,106 shares ($67.7K)

Jun 30, 2026 Inst.

MORGAN STANLEY — TRIM

160 shares ($360.00)

Insider ledger

Form 4

$128.5K

bought · 1 insider

sold · 0 insiders

+40.7%

vs their $3.76 cost

Date	Insider	Type	Value
Sep 30, 2026	Chang Kochi Director	EXERCISE	3,135 sh
Sep 30, 2026	Lu Shao-Ta Director	EXERCISE	3,135 sh
Sep 30, 2026	Chang Kochi Director	AWARD	3,135 sh
Sep 30, 2026	Lu Shao-Ta Director	AWARD	3,135 sh
Sep 14, 2026	Shen Ethan PhD CEO	BUY	$48.9K
Sep 9, 2026	Shen Ethan PhD CEO	BUY	$12.2K
Sep 4, 2026	Shen Ethan PhD CEO	BUY	$67.4K
Jun 30, 2026	Chang Kochi Director	EXERCISE	5,749 sh